Stocks & Investing
Fri, August 2, 2024
[ Fri, Aug 02nd 2024
] - WOPRAI
Mon, July 29, 2024
[ Mon, Jul 29th 2024
] - WOPRAI
Thu, July 25, 2024
[ Thu, Jul 25th 2024
] - WOPRAI
Fri, May 17, 2024
[ Fri, May 17th 2024
] - WOPRAI
Thu, May 9, 2024
[ Thu, May 09th 2024
] - WOPRAI
Tue, May 7, 2024
[ Tue, May 07th 2024
] - WOPRAI
Thu, April 11, 2024
[ Thu, Apr 11th 2024
] - WOPRAI
Tue, March 19, 2024
[ Tue, Mar 19th 2024
] - WOPRAI
[ Tue, Mar 19th 2024
] - WOPRAI
Tue, March 12, 2024
[ Tue, Mar 12th 2024
] - WOPRAI
Mon, March 11, 2024
[ Mon, Mar 11th 2024
] - WOPRAI
Fri, March 1, 2024
[ Fri, Mar 01st 2024
] - WOPRAI
Tue, January 30, 2024
[ Tue, Jan 30th 2024
] - WOPRAI
[ Tue, Jan 30th 2024
] - WOPRAI
Wed, January 3, 2024
[ Wed, Jan 03rd 2024
] - WOPRAI
Tue, October 3, 2023
[ Tue, Oct 03rd 2023
] - WOPRAI
Fri, June 30, 2023
[ Fri, Jun 30th 2023
] - WOPRAI
Tue, May 2, 2023
[ Tue, May 02nd 2023
] - WOPRAI
Thu, April 27, 2023
[ Thu, Apr 27th 2023
] - WOPRAI
Tue, February 7, 2023
[ Tue, Feb 07th 2023
] - WOPRAI
Thu, November 10, 2022
[ Thu, Nov 10th 2022
] - WOPRAI
Fri, July 29, 2022
[ Fri, Jul 29th 2022
] - WOPRAI
Wed, May 11, 2022
[ Wed, May 11th 2022
] - WOPRAI
[ Wed, May 11th 2022
] - WOPRAI
Thu, March 3, 2022
[ Thu, Mar 03rd 2022
] - WOPRAI
Tue, December 21, 2021
[ Tue, Dec 21st 2021
] - WOPRAI
Thu, September 9, 2021
[ Thu, Sep 09th 2021
] - WOPRAI
Tue, August 10, 2021
Thu, June 17, 2021
[ Thu, Jun 17th 2021
] - WOPRAI
Tue, June 8, 2021
[ Tue, Jun 08th 2021
] - WOPRAI
Joel Beatty Maintained (BPMC) at Buy with Increased Target to $127 on, Aug 2nd, 2024
Joel Beatty of Baird, Maintained "Blueprint Medicines Corporation" (BPMC) at Buy with Increased Target from $112 to $127 on, Aug 2nd, 2024.
Joel has made no other calls on BPMC in the last 4 months.
There are 13 other peers that have a rating on BPMC. Out of the 13 peers that are also analyzing BPMC, 4 agree with Joel's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Peter Lawson of "Barclays" Maintained at Hold with Increased Target to $105 on, Monday, July 29th, 2024
- Michael Ulz of "Morgan Stanley" Maintained at Hold with Increased Target to $115 on, Friday, July 12th, 2024
- Andrew Berens of "Leerink Partners" Upgraded from Sell to Hold and Increased Target to $97 on, Monday, May 6th, 2024
- Christopher Raymond of "Piper Sandler" Maintained at Hold with Increased Target to $104 on, Friday, May 3rd, 2024
These are the ratings of the 9 analyists that currently disagree with Joel
- Ami Fadia of "Needham" Reiterated at Strong Buy and Held Target at $130 on, Thursday, August 1st, 2024
- Matthew Biegler of "Oppenheimer" Maintained at Buy with Increased Target to $125 on, Monday, July 8th, 2024
- Reni Benjamin of "JMP Securities" Reiterated at Buy and Held Target at $125 on, Friday, June 7th, 2024
- Sudan Loganathan of "Stephens & Co." Initiated at Buy and Held Target at $140 on, Tuesday, May 14th, 2024
- Terence Flynn of "Goldman Sachs" Maintained at Strong Buy with Increased Target to $168 on, Monday, May 6th, 2024
- Andrew Fein of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $135 on, Friday, May 3rd, 2024
- David Lebowitz of "Citigroup" Maintained at Strong Sell with Increased Target to $76 on, Friday, May 3rd, 2024
- David Nierengarten of "Wedbush" Reiterated at Buy and Held Target at $110 on, Friday, April 26th, 2024
- Bradley Canino of "Stifel" Maintained at Strong Buy with Increased Target to $130 on, Friday, April 26th, 2024
